CD19 and precursor B-cell acute lymphoblastic leukemia: Rabilloud et al. [119] performed single-cell sequencing analysis of leukemia cells from a patient with relapsed B-ALL, found that CD19-negative leukemia cells were present before CAR-T-cell therapy and confirmed that relapse was due to the cloning of these CD19-negative leukemia cells.